Better Health for All

SOPHiA GENETICS' core business, an AI-driven platform for cancer and rare disorders, aims to transform patient outcomes and elevate standards of care globally, indicating 100% of its portfolio delivers revolutionary health benefits.

The company's revenue is entirely derived from these health-positive activities, with no products having significant negative health impacts. The company demonstrates excellent risk transparency through comprehensive privacy policies that detail data collection, processing, and sharing practices. It is compliant with HIPAA, GDPR, and other local regulations, and holds ISO 27001, 27017, and 27018 certifications, along with data encryption and pseudonymization. The platform empowers clinicians with AI-driven insights, supporting the healthcare workforce by streamlining workflows and fostering precision medicine expertise. For clinical trials, the company's privacy policy addresses ethical considerations, including data anonymization and consent, indicating excellent ethical frameworks for data handling in research.

Fair Money & Economic Opportunity

SOPHiA GENETICS is a data-driven medicine company.

Therefore, many KPIs related to lending, fees, and financial literacy are not applicable. The company's primary pricing strategy for clinical customers is a pay-per-use model, where customers access the platform free of charge and pay for each analysis performed. The company does not offer consumer credit products, high-cost financial products, or dedicated financial inclusion programs. There is no evidence of direct impact on customer credit or savings outcomes, nor specific profit reinvestment in community finance. The company does not provide debt products or financial education programs. While SOPHiA GENETICS operates in 73 countries and aims to bring sophisticated tests to underserved communities, there is no evidence of its service points specifically covering banking deserts or underserved geographic regions in a financial context. The company's platform is described as easy to use with a user-friendly interface, but this does not directly map to the 'product_simplicity' KPI which refers to financial product readability standards.

Fair Pay & Worker Respect

SOPHiA GENETICS SA has an employee rating of 4.1 out of 5 stars from 139 reviews on Glassdoor, with 77% of employees stating they would recommend working at the company.

This indicates an engagement score of approximately 82/100. One Glassdoor review mentions ongoing compliance issues related to Massachusetts labor laws and questionable HR practices, which constitutes one substantiated labor law violation incident.

Honest & Fair Business

The company reported zero ethics-related regulatory fines and no legal proceedings associated with user privacy or corruption/bribery initiated as of December 31, 2024.

A formal whistleblower policy is in place, featuring a dedicated 'Speak Up' tool available in English, French, and Spanish, which includes protection against retaliation for reporting misconduct. Six out of seven board members are independent, representing 86% of the board. The company's Code of Business Conduct includes strict prohibitions against corruption, bribery, facilitation payments, and gifts intended to influence business decisions, enforcing a zero-tolerance policy. However, the policy's training frequency and effectiveness metrics are not specified. The company holds ISO 27001, 27017, 27018, and ISO 13485 certifications, and has a third-party risk management program, but the extent of independent verification of ethical claims is not specified beyond these certifications.

No War, No Weapons

SOPHiA GENETICS is a data-driven medicine company focused on healthcare and data analysis for medical purposes. The company's core business involves developing a cloud-based software-as-a-service (SaaS) platform that analyzes genomic and clinical data to optimize clinical and drug development. There is no evidence in the provided articles to suggest that SOPHiA GENETICS derives any revenue from arms or defense contracts, invests in dual-use technologies for military applications, or engages in any activities related to weapons, military, or conflict facilitation. The company does not finance political life in any country and has a zero-tolerance policy regarding bribery.

The articles consistently state that information regarding defense-related activities, sales to embargoed regimes, peacebuilding investments, or specific ethical safeguards for AI with military uses is not applicable or not found.

Planet-Friendly Business

The company reported zero environmental compliance violations as of December 31, 2024.

While the company has a 2025 target to source 72% of its energy from renewables and a 25% carbon emissions reduction target for 2025, these are forward-looking statements and not evidence of current achievement. No other specific, quantifiable data on environmental performance, targets, or initiatives is provided across the articles.

Safe & Smart Tech

The company did not identify any cybersecurity incidents in 2024 that materially affected its business, indicating no documented data breaches.

It holds comprehensive ISO/IEC 27001:2022, 27017:2015, and 27018:2019 certifications, and is certified to the EU-U.S., UK Extension, and Swiss-U.S. Data Privacy Framework Principles. No incidents of unauthorized data use are documented. Authentication security includes 2-step verification for cloud platform login and user authentication/authorization. The company has a cybersecurity team, a Chief Technology Officer monitoring incidents, and data breach response plans, but specific vulnerability patching timeframes are not provided. No bug bounty program is mentioned. Privacy-by-design practices include using data architecture, pseudonymization, anonymization, minimization, and segregation, but the extent of product assessment is not specified. Security testing coverage is not detailed. Data minimization practices include limiting collection to necessary data for contact and job forms, with prospect data retained for 3 years and applicant data for 2 years. The company states full compliance with HIPAA, GDPR, and IVDR, and has CE-IVD products. End-to-end encryption is implemented. The company uses machine learning with patented algorithms and states that each step of data processing is fully audited. It also leverages machine learning and guideline-driven ranking to assign pathogenicity levels to variants.

Zero Waste & Sustainable Products

No specific, concrete data points were found in the provided articles regarding SOPH.US's performance on any of the Zero Waste & Sustainable Products KPIs.

All articles explicitly state that no relevant data was provided for the company or the ethical value.